Collection of Biological Samples From Patients With Rare Neurological Diseases
NCT04698421 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-03-19
Summary
The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
Conditions
- Nervous System Diseases
Interventions
- BIOLOGICAL
-
Blood collection on admission and longitudinally
Biological samples will be collected in the normal diagnosis and follow-up process. Only blood will be taken in larger quantity (8 tubes of 7mL).
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Chloé Bost, PharmD, PhD · University Hospital, Toulouse
Eligibility
- Min Age
- 6 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-12
- Primary Completion
- 2030-01-01
- Completion
- 2030-09-03
Countries
- France
Study Locations
More Related Trials
-
RWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922 ·Status: UNKNOWN
-
Transcriptome Analysis of the Peripheral Blood in CIDP
NCT02404298 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers in Autoimmune Disease of Nervous System
NCT06502015 ·Status: RECRUITING
-
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
NCT05136976 ·Status: RECRUITING ·Phase: PHASE3
-
Immunotherapy and Paraneoplastic Neurological Syndromes
NCT02343211 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
NCT03320798 ·Status: COMPLETED
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Neuropathy and Anti-GFAP Antibodies
NCT05742087 ·Status: UNKNOWN
-
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
NCT02892890 ·Status: COMPLETED ·Phase: NA
-
Exploring Outcomes and Characteristics of Myasthenia Gravis 2
NCT06002945 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers in Polyradiculoneuropathies
NCT04249752 ·Status: UNKNOWN
-
AL Amyloidosis and Anti-CD38-Daratunumab
NCT06571864 ·Status: COMPLETED ·Phase: NA
-
Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study
NCT01287689 ·Status: COMPLETED
-
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT04881682 ·Status: RECRUITING ·Phase: PHASE2
-
Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies
NCT03268161 ·Status: COMPLETED
-
EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES
NCT06808581 ·Status: COMPLETED ·Phase: NA
-
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
NCT01623076 ·Status: ACTIVE_NOT_RECRUITING
-
A Registered Cohort Study of Immune-Mediated Neuropathies
NCT04292834 ·Status: UNKNOWN
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING
-
Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk
NCT02440126 ·Status: COMPLETED
-
Meningococcal Vaccination in Patients on Complement Inhibitors
NCT06906692 ·Status: ACTIVE_NOT_RECRUITING
-
Serum Auto-Antibodies in Neurological Diseases
NCT00704626 ·Status: ENROLLING_BY_INVITATION
-
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03861481 ·Status: COMPLETED ·Phase: PHASE2
-
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024 ·Status: RECRUITING ·Phase: NA
-
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
NCT01655394 ·Status: UNKNOWN